U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C12H19NO
Molecular Weight 193.2854
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ETAFEDRINE

SMILES

CCN(C)[C@@H](C)[C@H](O)C1=CC=CC=C1

InChI

InChIKey=IRVLBORJKFZWMI-JQWIXIFHSA-N
InChI=1S/C12H19NO/c1-4-13(3)10(2)12(14)11-8-6-5-7-9-11/h5-10,12,14H,4H2,1-3H3/t10-,12-/m0/s1

HIDE SMILES / InChI

Molecular Formula C12H19NO
Molecular Weight 193.2854
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Description

Etafedrine, a sympathomimetic agent that acts on the sympathetic receptors of the bronchial tree relaxing spasm in a manner similar to that of ephedrine, is a bronchodilator and a selective β2-adrenoreceptor agonist. Contraction of the guinea pig tracheal chain by acetylcholine or histamine was antagonized by etafedrine with a higher potency then ephedrine but with a lower potency than epinephrine (adrenaline). Etafedrine did not increase heart rate or force of contraction in guinea pig atria. Unlike ephedrine and tyramine, etafedrine did not induce the release of noradrenaline as was demonstrated in vitro in the perfused rabbit heart and instead acted as a selective β2 adrenoreceptor agonist. Etafedrine also belongs to the family of medications called decongestants. It works by narrowing blood vessels in the nasal passages, helping to relieve nasal stuffiness. Etafedrine has been used in pharmaceutical compositions, such as NETHAPRIN Expectorant, Nethaprin Dospan and Dalmacol, useful in the treatment of asthma and other respiratory disorders including chronic bronchitis.

Originator

Approval Year

Targets

Primary TargetPharmacologyConditionPotency

Conditions

ConditionModalityTargetsHighest PhaseProduct
Palliative
NETHAPRIN Expectorant
Palliative
NETHAPRIN Expectorant
Palliative
Dalmacol
Palliative
Nethaprin Dospan
Palliative
Nethaprin Dospan

Cmax

ValueDoseCo-administeredAnalytePopulation
0.1 μg/mL
24 mg single, oral
ETAFEDRINE plasma
Homo sapiens

T1/2

ValueDoseCo-administeredAnalytePopulation
6 h
24 mg single, oral
ETAFEDRINE plasma
Homo sapiens

Sourcing

PubMed

Sample Use Guides

In Vivo Use Guide
Dalmacol (each mL contains hydrocodone bitartrate 0.33 mg, etafedrine HCl 3.33 mg, sodium citrate 40 mg, and doxylamine succinate 1.2 mg) the recommended dose is 5 mL (1 teaspoonful) every 3 to 5 hours as needed, but not more than 30 mL in any 24-hour period for adults. For children 6 to 12 years of age, the recommended dose is 2.5 mL to 5 mL every 3 to 5 hours as needed, but not more than 15 mL in any 24-hour period. For children 1 to 6 years of age, the recommended dose is 1.25 mL to 2.5 mL every 3 to 5 hours as needed, but not more than 3 doses in any 24-hour period.
Route of Administration: Oral
In Vitro Use Guide
Effects of (-)-N-ethylephedrine (etafedrine) were studied on the tracheal chain preparation and the atria of the guinea pig and on the rabbit perfused heart. Contraction of the tracheal chain by acetylcholine or histamine was antagonized by etafedrine. Propranolol (5 X 10(-7) M) completely antagonized the bronchodilator effect of 10(-4) M etafedrine on the acetylcholine-evoked contraction. Etafedrine up to 3 X 10(-4) M did not increase heart rate or force of contraction in guinea pig atria. In contrast to tyramine and ephedrine (both 10(-5) M), etafedrine (10(-4) M) failed to release 3H-norepinephrine (noradrenaline) in the perfused rabbit heart. Moreover, the concentration-dependent positive chronotropic and inotropic effects of norepinephrine in isolated atria were slightly, but not significantly enhanced by etafedrine.
Substance Class Chemical
Record UNII
2Y6VQU63E8
Record Status Validated (UNII)
Record Version